Drreddys Laboratories | RDY - Le Coût Des Ventes





Le Coût Des Ventes Changement Date
ANI Pharmaceuticals USD 122.88M 6.86M 2025-12
Aurora Cannabis CAD 88.61M 30.53M 2025-12
Bayer EUR 4.5B 194M 2025-12
Canopy Growth CAD 53.08M 8.3M 2025-12
Cipla INR 29.1B 1.16B 2025-12
Corcept Therapeutics USD 2.54M 2.05M 2025-12
Drreddys Laboratories INR 40.46B 3.64B 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Lonza CHF 2.28B 189M 2025-06
Novartis USD 3.54B 3M 2025-12
Pacira USD 54.62M 6.02M 2025-12
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 131.22M 3.52M 2025-12
Richter Gedeon HUF 71.32B 1.01B 2025-09
Sun Pharmaceuticals INR 36.77B 348M 2025-12
Supernus Pharmaceuticals USD 47.53M 4.24M 2025-12
Teva Pharmaceutical Industries USD 2.06B 120M 2025-12